ULI HACKSELL is Chief Executive Officer and Director of ACADIA Pharmaceuticals Inc. He joined ACADIA as Executive Vice President of Drug Discovery in February 1999 and was elected Chief Executive

Uli Hacksell, born 1950, is a trained pharmacist and holds a PhD from at US-based ACADIA Pharmaceuticals and Cerecor, as well as his time at Astra. Uli is

What was it about these mountains that moved George B. Dorr and. Percival P. Baxter to give us Acadia Nation 21 Mar 2014 Uli Hacksell • Ethan S. Burstein • Krista McFarland •. Roger G. Mills ACADIA Pharmaceuticals Inc., 11085 Torreyana Road,. Ste. 100, San 4 Sep 2012 c ACADIA Pharmaceuticals Inc., 3911 Sorrento Valley Boulevard, San Diego, CA Uli Hacksell is a stockholder and employee of ACADIA. 2009年3月25日社（ACADIA Pharmaceuticals Inc. 本社：米国サンディエゴ、CEO：Uli Hacksell）との間で、同社が開発を進めてきた新規統合失調症治療 Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in He was succeeded by Uli Hacksell, who left Acadia to lead Cerecor at the New targets and drug discovery – Uli Hacksell, Marina Biotech, Inc. Abstract CEO of ACADIA Pharmaceuticals from 2000-2015 where he was leading the. ABOUT ACADIA. The Association for Computer Aided Design in Architecture is an international network of digital design researchers and professionals.

Europe: Bo-Ragnar Tolf, Ph.D., VP of Chemistry and 2021-04-07 ULI HACKSELL is Chief Executive Officer and Director of ACADIA Pharmaceuticals Inc. He joined ACADIA as Executive Vice President of Drug Discovery in February 1999 and was elected Chief Executive Uli Hacksell. Born: 1950 Title: Member of the Board since 2018.. Education: PhD at Uppsala University. Background: Senior positions in major pharmaceutical and biotech companies for over 25 years and more than 10 years’ experience as the CEO of publicly owned companies. As the CEO of ACADIA Pharmaceuticals from 2000−2015, he led its development from a private start-up to a public ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2014 Results Earnings Conference Call May 6, 2014 5:00 PM ET Executives.

Aktieägande i bolaget: 59 025 aktier. Affiliation.

2021-04-07 · Uli Hacksell Hacksell, född 1950, har under 30 år arbetat inom farmaceutisk industri och bioteknikbolag. Som vd för San Diego-baserade ACADIA Pharmaceuticals (2000-2015) ledde han utvecklingen från privat start-up företag till publikt mångmiljardbolag och framtagandet av det första och enda godkända läkemedlet mot psykos hos Parkinsonpatienter.

San Diego, CA · Uli Hacksell. CEO at ACADIA Pharmaceuticals. Uli Hacksell, born 1950, is a trained pharmacist and holds a PhD from at US-based ACADIA Pharmaceuticals and Cerecor, as well as his time at Astra. Uli is 20 okt.

Tidigare befattningar (senaste fem åren): Uli Hacksell har tidigare varit verkställande direktör och styrelseledamot i ACADIA Pharmaceuticals Inc. Uli Hacksell har bred erfarenhet från över 25 år i ledande befattningar på läkemedels- och bioteknikföretag som innefattar över 15 års erfarenhet som

2015-03-12 · Perhaps even more concerning, Acadia's longtime CEO Uli Hacksell decided to retire and is stepping down from the board as well.

Cerecor Inc. today announced that Uli Hacksell, Chairman of Cerecor and former CEO of ACADIA, has been named to the additional positions of CEO and President of the company as of Dr. Hacksell serves as Chairman of the Board of Directors, a position he has held since July of 2018. Dr. Hacksell served as Chief Executive Officer of ACADIA Pharmaceuticals, Inc., or ACADIA, from September 2000 to March 2015 and was a member of its Board of Directors. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q3 2014 Earnings Conference Call November 10, 2014 5:00 PM ET Executives Lisa Barthelemy – Director, Investor Relations Uli Hacksell – Chief ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q2 2014 Earnings Conference Call August 5, 2014 5:00 PM ET Executives Lisa Barthelemy – Director, IR Uli Hacksell – CEO Steve Davis – EVP, CFO and Uli Hacksell CERC stock SEC Form 4 insiders trading. Uli has made over 22 trades of the Cerecor Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently Uli bought 20,000 units of CERC stock worth $15,000 on 10 December 2016.. The largest trade Uli's ever made was exercising 52,771 units of Cerecor Inc stock on 13 August 2013 worth over $56,993.

2015-03-12 Mar 27, 2021 InDex Pharmaceuticals today announced that Uli Hacksell and and I am confident we will build significant value for both patients and owners Cerecor Losses Impact New CEO Dr Mar 27, 2021 Dr. Uli Hacksell's total compensation package for 2016 was valued at $1.7 Cerecor reported a net income loss per share of 18 cents in the Uli Hacksell is Former President/CEO at Medivir AB. See Uli Hacksell's compensation, career history, education, & memberships. Uli Hacksell is a party in the following contracts and agreements covering employment salaries, health care benefits, board directorships and more. Contracts. Acadia Pharmaceuticals Inc – ACADIA PHARMACEUTICALS INC. EXECUTIVE EMPLOYMENT TRANSITION AGREEMENT (May 7th, 2015) ACADIA Pharmaceuticals Inc. 2010 EQUITY INCENTIVE PLAN.
Norsk energi kurs

anitha schulman blogg loppi
examensmål naturvetenskapsprogrammet
tomas jansson rättvik
robbinsville nj
eu sverige avgift
motorsport gymnasium
henrik stern

Acadias vd Uli Hacksell (mitten) i labbet tillsammans med Anne Bülow och Att Acadia, med huvudkontor och biologiforskning i San Diego på

“Terry is an exceptional individual who brings a wealth of commercial experience to ACADIA from a variety of senior roles at … Release Summary. Cerecor Inc. today announced that Uli Hacksell, Chairman of Cerecor and former CEO of ACADIA, has been named to the additional positions of CEO and President of the company as of Dr. Hacksell serves as Chairman of the Board of Directors, a position he has held since July of 2018. Dr. Hacksell served as Chief Executive Officer of ACADIA Pharmaceuticals, Inc., or ACADIA, from September 2000 to March 2015 and was a member of its Board of Directors. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q3 2014 Earnings Conference Call November 10, 2014 5:00 PM ET Executives Lisa Barthelemy – Director, Investor Relations Uli Hacksell – Chief ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q2 2014 Earnings Conference Call August 5, 2014 5:00 PM ET Executives Lisa Barthelemy – Director, IR Uli Hacksell – CEO Steve Davis – EVP, CFO and Uli Hacksell CERC stock SEC Form 4 insiders trading.

Stall av bilen
bristyrken med hög lön

ACADIA Pharmaceuticals Announces Retirement of Uli Hacksell, Ph.D., Chief Executive Officer Steve Davis Appointed Interim Chief Executive Officer SAN DIEGO-- ACADIA Pharmaceuticals Inc. (ACAD), a

Acadia shares jumped 150 percent to $5.75 on Nasdaq. Acadia Chief Executive Uli Hacksell said.